L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Nature communications
View this publicationNature communications
View this publicationiScience
View this publicationAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
View this publicationCellular and molecular life sciences : CMLS
View this publicationCells
View this publicationClinical lung cancer
View this publicationHeliyon
View this publicationKidney international
View this publicationCardiovascular revascularization medicine : including molecular interventions
View this publicationInternational journal of molecular sciences
View this publication